Sciamed Ltd have signed a distributor agreement with Tridentify
Tridentify are pleased to announce that Sciamed Ltd. have signed a distributor agreement for the Territory of UK and Ireland. Tridentify’s quality cold chain solution – monitoring the shelf-life of any biologic and pharma products during storage and transportation. Markets served will be both the healthcare sector as well as the clinical trial industry. Launch of the partnership and the QTA Tracer System will be done at ICTMC in Edinburgh (International Clinical Trial Methodology Conference) next week 30th Sept – 3rd Oct.
“Sciamed Ltd is delighted to be collaborating with Tridentify to bring their shelf-life temperature monitoring system to the UK Healthcare market. There is a strong synergy between the two companies and a shared ethos of delivering high-quality products and services that have a positive impact to patient care and operational efficiency, ”says Stephen Henry, Director of Sciamed Ltd.
“Tridentify are excited about the partnership and look forward to close collaboration with Sciamed Ltd. Together with Sciamed we want to ensure high quality standards and provide cold chain integrity solutions to NHS and others. Our continued effort to provide sustainable quality solutions to monitor temperature sensitive products to the British market will be enhanced,” says Ann-Christine Jungmar, CEO at Tridentify.
About Tridentify AB
Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for costly sensitive drugs, vaccines, blood, plasma, organs and other temperature-sensitive goods. The company has a unique and patented SaaS/IoMT system that monitors the status of the products’ shelf-life in real time and continuously calculates its remaining shelf-life and that it safely fulfils its purpose. With the Safeguarding solution, you always have a close eye on how your temperature sensitive products are doing during the journey.
The uniqueness of QTA Tracer System® is the MDD* certification, that enables automatic release due to the systems certified decision capacity, to calculate the remaining shelf-life/stability budget of any biologic or pharma products. With our medical technology - not just a logistics tool - sensitive goods can be put into use immediately after delivery without a formal QA decision. Our technology makes it safe and easy to comply with current and future legislation and requirements. In the end, this means safe products, safe patients and minimal waste.
* Tridentify has a SaaS solution using a unique IoT Tracer that is a MDD MedTech Device Class IIa.
MDD Certificate extended to end of 2028 due to Article 120 of MDR
For more information, visit tridentify.com
About Sciamed Ltd
Sciamed Ltd, is a private, UK based technology company engaged in the Healthcare market, providing complete solutions for bar code scanning and printing; laboratory inventory management and laser marking to identify surgical instruments. Established in 1994, the Company has a proven track record in providing robust technology solutions across a wide variety of applications and departments in the NHS. The aim of the Company is to be the leading provider of bar code labelling and identification systems to the Healthcare Sector in the UK based on extensive product and application knowledge, innovative solutions that exceed customer expectations, all backed by first-class customer service.
For more information, visit Sciamed Ltd
For further information, kindly contact:
Ann-Christine Jungmar, CEO Tridentify
+46 708 71 46 76
ann-christine.jungmar@tridentify.com
Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for costly sensitive drugs, vaccines, blood, plasma, organs and other temperature-sensitive goods. The company has a unique and patented SaaS/IoMT system that monitors the status of the products’ shelf-life in real time and continuously calculates its remaining shelf-life and that it safely fulfils its purpose. With the Safeguarding solution, you always have a close eye on how your temperature sensitive products are doing during the journey.
The uniqueness of QTA Tracer System® is the MDD* certification, that enables automatic release due to the systems certified decision capacity, to calculate the remaining shelf-life/stability budget of any biologic or pharma products. With our medical technology - not just a logistics tool - sensitive goods can be put into use immediately after delivery without a formal QA decision. Our technology makes it safe and easy to comply with current and future legislation and requirements. In the end, this means safe products, safe patients and minimal waste.
Tridentify has a SaaS solution using a unique IoT Tracer that is a MDD MedTech Device Class IIa*.
*MDD Certificate extended to end of 2028 due to Article 120 of MDR
For more information, visit tridentify.com
